داستان در حال پیگیری · ۱ گزارش
The ChAdOx1 BDBV Phase I vaccine trial
در حال تحولبررسی بعدی : Further enrollment and dosing, safety monitoring, and reported study results.
وضعیت کنونی
The Phase I safety study began with the first volunteer receiving a dose of ChAdOx1 BDBV in England on July 24, 2026. The study plans to enroll 50 healthy adults; enrollment, safety monitoring and results remain open, and the report gives no date for a next step.
پیگیری خبرروز 1
1 گزارش9 رسانه11 منبع1 ویدئو
- هنوز رویداد تاریخداری نیست
خبر تا این لحظه
First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000
Oxford gave the first Bundibugyo Ebola vaccine dose on 24 July as Central Africa's death toll passed 1,000 — with the exact count still disputed.
پس از این گزارش هنوز روشن نیست
- No verified final case and death counts, volunteer identity, or verbatim leadership quotes in provided sources.
- No confirmed WHO emergency declaration wording or results date in provided sources.
تاریخچه
آغاز شد۱ گزارش
چه کسانی درگیرند
افراد
Richard HatchettAmerican epidemiologist۱ گزارش
مکانها
- Democratic Republic of the CongoDemocratic Republic of the Congo۱ گزارش
- OxfordOxford, UK۱ گزارش
- UgandaUganda۱ گزارش
همه رسانههایی که درباره این خبر خواندیم
11 منبع9 رسانه1 ویدئو1 متن خبرگزاری
ox.ac.uk3
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial — Oxford Vaccine Group
- First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial — Pandemic Sciences Institute
- World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group — Oxford Vaccine Group
Africanewsafricanews.com1
HeyDay News1۱ ویدئو
medicalxpress.com1
thepharmacist.co.uk1
